RaymondEDe La RosaMD

Endocrinology • Sarasota, FL

Diabetes, Lipid Metabolism, Parathyroid, Thyroid

Physician

Join to view full profile

Dr. De La Rosa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. De La Rosa's full profile

Already have an account?

Office
8383 S Tamiami Trl
Unit 115
Sarasota, FL 34238
Phone+1 941-841-4206

Fax+1 941-841-4209

Summary

Dr. Raymond de la Rosa is an Endocrinologist in Englewood, FL. A graduate of the University of the Philippines College of Medicine, he completed his residency in Internal Medicine at the Lutheran Medical Center (now NYU - Langone Hospital) and fellowship in Endocrinology, Diabetes and Metabolism at Brown University. Dr. de la Rosa has been in practice for over 24 years.

Education & Training

Brown UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 1990 - 1993
University of the Philippines College of MedicineClass of 1989

Certifications & Licensure

FL State Medical License 2017 - 2025
OR State Medical License 2019 - 2021
KY State Medical License 1994 - 2017
NC State Medical License 2004 - 2013
AR State Medical License 1998 - 2005
OK State Medical License 1998 - 2004
RI State Medical License 1993 - 1996
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Publications & Presentations

PubMed

2 citations
Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.
Louis B. Chaykin, Anuj Bhargava, Raymond de la Rosa, Carol Wysham, Lone Nørgård Troelsen
Clinical Diabetes. 2019-01-01
214 citations
Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.
Helena W. Rodbard, Ildiko Lingvay, John C. Reed, Raymond de la Rosa, Ludger Rose
The Journal of Clinical Endocrinology and Metabolism. 2018-06-01
171 citations
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis B. Chaykin, Raymond de la Rosa, Yehuda Handelsman
JAMA. 2017-07-04